Chronic Obstructive Pulmonary Disease Analysis Report 2023: A Global $31.25+ Billion Industry by 2032 Featuring Leading Players – AstraZeneca, Orion, Novartis, Teva, GSK, Mylan, & CHIESI Farmaceutici

DUBLIN, July 13, 2023 /PRNewswire/ — The “Chronic Obstructive Pulmonary Disease Market Size, Trends, Industry Analysis Report, By Drug Type, By Product Type, By Region, Segment Forecast, 2023 – 2032” report has been added to ResearchAndMarkets.com’s offering. The chronic obstructive…